Bioresorbable Vascular Scaffolds Restenosis Pathophysiology and Predictors

被引：8

作者：

Alfonso, Fernando ^{[1
]}

Cuesta, Javier ^{[1
]}

机构：

[1] Hosp Univ La Princesa, Dept Cardiol, Madrid, Spain

来源：

JACC-CARDIOVASCULAR INTERVENTIONS | 2017年 / 10卷 / 18期

关键词：

OPTICAL COHERENCE TOMOGRAPHY; IN-STENT RESTENOSIS; IMPLANTATION; METAANALYSIS; TRIALS;

D O I：

10.1016/j.jcin.2017.08.025

中图分类号：

R5 [内科学];

学科分类号：

100201 [内科学];

摘要：

引用

页码：1828 / 1831

页数：4

共 16 条

[1]

Alfonso F, 2017, REV ESP CARDIOL, V70, P527, DOI [10.1016/j.rec.2017.02.024, 10.1016/j.recesp.2016.12.008]

[2]

Very Late Bioresorbable Vascular Scaffold Thrombosis Smoke or Fire? [J].

Alfonso, Fernando ;

Cuesta, Javier .

JACC-CARDIOVASCULAR INTERVENTIONS, 2017, 10 (01) :38-41

[3]

Current Treatment of In-Stent Restenosis [J].

Alfonso, Fernando ;

Byrne, Robert A. ;

Rivero, Fernando ;

Kastrati, Adnan .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2014, 63 (24) :2659-2673

[4]

2-year outcomes with the Absorb bioresorbable scaffold for treatment of coronary artery disease: a systematic review and meta-analysis of seven randomised trials with an individual patient data substudy [J].

Ali, Ziad A. ;

Serruys, Patrick W. ;

Kimura, Takeshi ;

Gao, Runlin ;

Ellis, Stephen G. ;

Kereiakes, Dean J. ;

Onuma, Yoshinobu ;

Simonton, Charles ;

Zhang, Zhen ;

Stone, Gregg W. .

LANCET, 2017, 390 (10096) :760-772

[5]

Recurrent Neoatherosclerosis After Bioresorbable Vascular Scaffold Treatment of In-Stent Restenosis [J].

Bastante, Teresa ;

Rivero, Fernando ;

Benedicto, Amparo ;

Cuesta, Javier ;

Alfonso, Fernando .

JACC-CARDIOVASCULAR INTERVENTIONS, 2015, 8 (09) :1264-1265

[6]

Everolimus-eluting bioresorbable vascular scaffolds versus everolimus-eluting metallic stents: a meta-analysis of randomised controlled trials [J].

Cassese, Salvatore ;

Byrne, Robert A. ;

Ndrepepa, Gjin ;

Kufner, Sebastian ;

Wiebe, Jens ;

Repp, Janika ;

Schunkert, Heribert ;

Fusaro, Massimiliano ;

Kimura, Takeshi ;

Kastrati, Adnan .

LANCET, 2016, 387 (10018) :537-544

[7]

Chavarría J, 2017, REV ESP CARDIOL, V70, P543, DOI [10.1016/j.rec.2016.10.002, 10.1016/j.recesp.2016.09.034]

[8]

Malabsorption of a Bioresorbable Vascular Scaffold System Leading to Very Late In-Scaffold Restenosis More Than 3.5 Years After Implantation Assessment by Optical Coherence Tomography [J].

Dommasch, Michael ;

Langwieser, Nikolas ;

Laugwitz, Karl-Ludwig ;

Ibrahim, Tareq .

JACC-CARDIOVASCULAR INTERVENTIONS, 2016, 9 (24) :2571-2572

[9]

Neointimal Proliferation Is Associated With Clinical Restenosis 2 Years After Fully Bioresorbable Vascular Scaffold Implantation [J].

Indolfi, Ciro ;

Mongiardo, Annalisa ;

Spaccarotella, Carmen ;

Caiazzo, Gianluca ;

Torella, Daniele ;

De Rosa, Salvatore .

CIRCULATION-CARDIOVASCULAR IMAGING, 2014, 7 (04) :755-757

[10]

Anatomical features and management of bioresorbable vascular scaffolds failure: A case series from the GHOST registry [J].

Longo, Giovanni ;

Granata, Francesco ;

Capodanno, Davide ;

Ohno, Yohei ;

Tamburino, Claudia Ina ;

Capranzano, Piera ;

La Manna, Alessio ;

Francaviglia, Bruno ;

Gargiulo, Giuseppe ;

Tamburino, Corrado .

CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2015, 85 (07) :1150-1161

← 1 2 →